For our #bladdercancer community this is the 1st time novel therapies have improved outcomes over chemo. EV-pembro combo improving both overall and progression free survival endpoints is huge. Looking forward to seeing the data ESMO - Eur. Oncology #ESMO23!!

J'ai eu très peur mais avec Lazare on a fait cette CASCADE à la Alex Thomson ! 💥 Partagez un max cette vidéo, pour nous aider à faire entendre parler de notre Vendée Globe et sortir des personnes de la rue grâce à cette visibilité ! A voir ici : youtu.be/lIHD6WBQOWE?si…

🌿 L’Académie française, dans sa séance du jeudi 28 septembre 2023, a procédé à l’élection du nouveau Secrétaire perpétuel.   M. Amin Maalouf a été élu, en remplacement de Mme Hélène Carrère d’Encausse, décédée le 5 août dernier.

Coucher de soleil Golfe du #Morbihan, #Bretagne

EV302 abstract: EV/pembro improves OS to 31.5 months c/w 16.1 months for chemo. Looking forward to seeing the data but this is transformative for the field and will change the standard of care. Memorial Sloan Kettering Cancer Center Tom Powles Bladder Cancer Advocacy Network Matt Galsky Andrea Apolo, M.D.

Wow. 3 ADCs! B7-H3, HER3 DXd and CDH6! Hope to move the needle fwd faster! OncoAlert Merck signs $5.5 billion deal with Daiichi for cancer therapy development reuters.com/business/healt…

#Goosebumps #EV302 #ESMO23 Took 3 decades but a new SOC in 1L bladder cancer !!!!!! ⁦Tom Powles⁩ EV+Pembro irrespective…..WOW! 🤩

Simply "presidential"! Tom Powles presents the first combinations thats beats chemotherapy in 1L mUC for survival!! At 17.2mo f/up PFS HR=0.45, OS HR=0.47 Congrats to the investigators, scientific community and patients! #ESMO23 ESMO - Eur. Oncology OncoAlert

EV302 Tom Powles standing ovation #ESMO23 I’m not crying you’re crying

Enfortumab vedotin & Pembrolizumab improving PFS & OS by 55% & 53% respectively compared to platinum based chemo in 1st line UC (+avelumab in 30%). Chemo has not been beaten before (despite multiple efforts). RR and CR of 68% & 29% is hard to beat. DOR not reached (1/3)#ESMO2023

For all the trials and patients who contributed, for all the negative trials before, this standing ovation for the #EV302 trial is for all of them! Tom Powles acknowledges all who went before. ESMO - Eur. Oncology #ESMO23 OncoAlert

EV-302 data changes the game in metastatic UC. Congrats to Tom Powles for a well conducted study and great presentation, and to the entire EV-302 study team Gopa Iyer. Congrats to Andrea Apolo, M.D. for her insightful discussion. Memorial Sloan Kettering Cancer Center Michiel van der Heijden Bladder Cancer Advocacy Network

JUST IN (and finally...): Pembrolizumab hits OVERALL SURVIVAL in KYN-564 adjuvant study in Kidney Cancer!!! The time has finally come... via Business Wire Dana-Farber Lank Center for Genitourinary Oncology Tom Powles OncoAlert Oncology Brothers OncLive.com Targeted Oncology UroToday.com Uromigos Alliance for Clinical Trials in Oncology ECOG-ACRIN Cancer Research Group SWOG Cancer Research Network

The official music video for ‘Now And Then’ is live on YouTube directed by Peter Jackson. TheBeatles.lnk.to/NowAndThenVideo He describes finding “a collection of unseen outtakes in the vault, where the Beatles are relaxed, funny and rather candid. We wove humour into some footage shot in

Brandenburg Gate in Berlin 🇩🇪, tonight: “Never again is now!”

Now & Then…. I Miss You ❤️

Enfortumab Vedotin + pembro shows broad spectrum of activity for RR PFS and OS in all subgroups. This includes subsets such as lymph node disease, liver mets, PD-L1 status, upper tract disease, platinum eligibility. This +ve data underlines EVP as a new standard of care #GU24

Après, si les citoyens français préfèrent la ruine du pays en votant Rassemblement National , perdre leur épargne, les allocs et autres pensions de retraite ne plus être financées , que voulez-vous?

Coup de cœur pour ce combo Lady Gaga / Garde Républicaine 🩵